- Amended Statement of Ownership: Solicitation (SC 14D9/A)
March 12 2010 - 3:23PM
Edgar (US Regulatory)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14D-9
(Rule 14d-101)
Solicitation/Recommendation Statement
Under Section 14(d)(4) of the Securities Exchange Act of 1934
(Amendment No. 2)
HOME DIAGNOSTICS, INC.
(Name of Subject Company)
HOME DIAGNOSTICS, INC.
(Name of Person Filing Statement)
Common Stock, par value $0.01 per share
(Title of Class of Securities)
437080104
(Cusip Number of Class of Securities)
Peter Ferola, Esq.
Vice President and General Counsel
Home Diagnostics, Inc.
2400 NW 55
th
Court
Fort Lauderdale, Florida 33309
(954) 677-9201
(Name, address and telephone number of person authorized to
receive notices and communications on behalf of
the person(s) filing statement)
With copies to:
|
|
|
Clifford E. Neimeth, Esq.
Greenberg Traurig, LLP
MetLife Building
200 Park Avenue
New York, New York 10166
(212) 801-9383
|
|
Edwin T. Markham, Esq.
Satterlee Stephens Burke & Burke LLP
230 Park Avenue
New York, New York 10169
(212) 818-9200
|
o
Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer.
TABLE OF CONTENTS
This Amendment No. 2 (this
Amendment No. 2
) to the Solicitation/Recommendation Statement on
Schedule 14D-9 of Home Diagnostics, Inc., a Delaware corporation (the
Company
), hereby amends
and supplements Item 8 and Item 9 of the Solicitation/Recommendation Statement on Schedule 14D-9
originally filed with the Securities and Exchange Commission on February 11, 2010 by the Company
(as hereby amended, the
Statement
).
The Statement relates to the cash tender offer by Nippon Product Acquisition Corporation
(
Purchaser
), a Delaware corporation and wholly-owned subsidiary of Nipro Corporation, a company
organized and existing under the laws of Japan (
Parent)
, to purchase all of the issued and
outstanding common stock of the Company, par value $0.01 per share, at a price of $11.50 per share
(the
Offer Price
), net to the seller in cash, without interest thereon and less any required
withholding taxes, and otherwise on the terms and subject to the conditions set forth in the Offer
to Purchase dated February 11, 2010, and in the related Letter of Transmittal, copies of which are
attached to the Tender Offer Statement on Schedule TO, filed by Purchaser and Parent with the SEC
on February 11, 2010, as exhibits (a)(1) and (a)(2) thereto, respectively.
Except as amended and supplemented by the information expressly set forth in this Amendment No. 2,
the information set forth in the Statement remains unchanged and is hereby incorporated by
reference into this Amendment No. 2.
All capitalized terms used but not specifically defined in this Amendment No. 2 have the respective
meanings ascribed to them in the Statement.
Item 8.
Additional Information
.
Item 8 of the Schedule 14D-9 is amended and supplemented with the addition of the following
section:
The Offer.
The Offer expired at 12:00 midnight, New York City time, on Thursday, March 11, 2010.
According to Wells Fargo Bank, National Association, the depositary for the Offer, 16,293,824
shares of the Companys common stock (including 374,405 shares of common stock tendered by notice of
guaranteed delivery) were validly tendered in the Offer and not withdrawn, representing
approximately 95.85% of the outstanding Shares. Purchaser has accepted for payment all tendered
Shares and payment will be made promptly.
On March 12, 2010, the Company and Parent issued a joint press release announcing the results
of the Offer as of the expiration of the Offer period. A copy of the press release announcing the
results of the Offer is attached hereto as Exhibit (a)(7) and is incorporated herein by reference.
Item 9.
Exhibits
.
Item 9 of the Statement is hereby amended and supplemented by adding the following exhibit
thereto:
|
|
|
Exhibit
|
|
|
Number
|
|
Description
|
(a)(7)
|
|
Press release issued by the Company and Nipro Corporation on March 12, 2010.
|
SIGNATURE
After due inquiry and to the best of my knowledge and belief, I certify that
the information set forth in this Statement is true, complete and correct.
|
|
|
|
|
|
HOME DIAGNOSTICS, INC.
|
|
Dated: March 12, 2010
|
By:
|
/s/ Peter F. Ferola
|
|
|
|
Name:
|
Peter F. Ferola
|
|
|
|
Title:
|
Vice President and General Counsel
|
|
|
Home Diagnostics (MM) (NASDAQ:HDIX)
Historical Stock Chart
From Apr 2024 to May 2024
Home Diagnostics (MM) (NASDAQ:HDIX)
Historical Stock Chart
From May 2023 to May 2024